| Descriptor English: | Mopidamol | ||||||
| Descriptor Spanish: |
Mopidamol
| ||||||
| Descriptor Portuguese: | Mopidamol | ||||||
| Descriptor French: | Mopidamol | ||||||
| Entry term(s): |
RA-233 Rapenton |
||||||
| Tree number(s): |
D03.383.742.430 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D009012 | ||||||
| Scope note: | A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Antineoplastic Agents |
||||||
| Registry Number: | 4Q0IWP8B8O | ||||||
| CAS Type 1 Name: | Ethanol, 2,2',2'',2'''-((4-(1-piperidinyl)pyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis- | ||||||
| Previous Indexing: |
Ethanolamines (1973-1974) Piperidines (1971-1974) Pyrimidines (1971-1974) |
||||||
| Public MeSH Note: | 91; was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84 |
||||||
| Online Note: | use MOPIDAMOL to search RA 233 1975-84 |
||||||
| History Note: | 91(85); was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84 |
||||||
| DeCS ID: | 9202 | ||||||
| Unique ID: | D009012 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1991/01/01 | ||||||
| Date of Entry: | 1974/11/19 | ||||||
| Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Mopidamol
- Preferred
Rapenton
- Narrower
RA-233
- Narrower
| Concept UI |
M0014050 |
| Scope note | A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic. |
| Preferred term | Mopidamol |
| Concept UI |
M0374383 |
| Preferred term | Rapenton |
| Concept UI |
M0374384 |
| Preferred term | RA-233 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey